Home » Topics » BioWorld Science, Conferences

BioWorld Science, Conferences
RSS

Ad5.SSTR/TK.RGD/ganciclovir active in phase I trial in gynecologic cancer

May 21, 2010

Dofetilide shows clinical potential for treatment of persistent AF

May 21, 2010

Diannexin reduces ischemia/reperfusion injury in renal transplant recipients

May 21, 2010

TOL-101 antibody modulates T-cell responses in vitro and in vivo

May 21, 2010

Updates on ADX-10059 for clinical management of GERD

May 21, 2010

Early indomethacin reduces early atrial fibrillation recurrence after AF ablation

May 20, 2010

Odanacatib promising in phase II trial in postmenopausal women with low BMD

May 20, 2010

JAK2 inhibitor TG-AZ1 sensitizes lung cancer cells to radiation

May 20, 2010

Myriad's candidate anticancer therapeutics inhibit Nampt

May 20, 2010

Promising preclinical profile of MEK kinase inhibitor TAK-733

May 20, 2010

Popular Stories

Today's news in brief
BioWorld
Precision psychiatry beyond, or before, biomarkers
BioWorld
There is broad agreement that psychiatric diagnoses in their current form are not reflective of any underlying biology, and that this is one of the things...
Keros reports beneficial effects of RKER-065 in ALS model
BioWorld Science
Keros Therapeutics Inc. has presented data regarding their activin receptor ligand trap, RKER-065, for the inhibition of the activin/myostatin signaling axis.
News in brief
BioWorld Asia
BioWorld Asia briefs for March 17, 2026
First-in-class POLG activator restores mtDNA across mutations
BioWorld Science
Researchers from Pretzel Therapeutics Inc. presented preclinical data of PX-578, a first-in-class POLG activator aimed at restoring mtDNA replication and...